XYLT1 and systemic sclerosis: In the study by Ly et al., decreased KLF4 mRNA expression was detected in fibroblasts from systemic sclerosis patients compared with control fibroblasts, along with increased XYLT1 mRNA expression and increased XT-I activity [37].